Overexpression of cyclooxygenase-2 in childhood ependymomas: Role of COX-2 inhibitor in growth and multi-drug resistance in vitro

Oncology Reports

Volumn 12, Issue 2, 2004, Pages 403-409

  Kim, Seung Ki ^a   Lim, Su Young ^a   Wang, Kyu Chang ^a   Kim, Young Yim ^a   Chi, Je G ^a   Choi, Yoon L A ^a   Shin, Hyung Jin ^b   Cho, Byung Kyu ^a  

^a Seoul National University Hospital   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Apoptosis; Cyclooxygenase 2; Ependymoma; Multi drug resistance; NS 398

Indexed keywords

COLORING AGENT; CYCLOOXYGENASE 2; ENZYME INHIBITOR; GLYCOPROTEIN P; ISOENZYME; LIPOCORTIN 5; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN; RHODAMINE 123;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; BRAIN TUMOR; CELL CULTURE; CELL PROLIFERATION; CHILD; DOSE RESPONSE; DRUG RESISTANCE; EPENDYMOMA; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; MALE; METABOLISM; MULTIDRUG RESISTANCE; PRESCHOOL CHILD; TIME; WESTERN BLOTTING;

ANNEXIN A5; APOPTOSIS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; COLORING AGENTS; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; EPENDYMOMA; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; ISOENZYMES; MALE; MEMBRANE PROTEINS; P-GLYCOPROTEIN; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RHODAMINE 123; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 16544394060     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.2.403     Document Type: Article

References (30)

1. Gjerris F, Agerlin N, Borgesen SE, Buhl L, Haase J, Klinken L, Mortensen AC, Olsen JH, Ovesen N, Reske-Nielsen E and Schmidt K: Epidemiology and prognosis in children treated for intracranial tumours in Denmark 1960-1984. Childs Nerv Syst 14: 302-311, 1998. (Pubitemid 28363875)
2. Tomita T: Neurosurgical perspectives in pediatric neurooncology. Childs Nerv Syst 14: 94-96, 1998.
3. Figarella-Branger D, Civatte M, Bouvier-Labit C, Gouvernet J, Gambarelli D, Gentet JC, Lena G, Choux M and Pellissier JF: Prognostic factors in intracranial ependymomas in children. J Neurosurg 93: 605-613, 2000. (Pubitemid 32799294)
4. Pollack IF, Gerszten PC, Martinez AJ, Lo KH, Shultz B, Albright AL, Janosky J and Deutsch M: Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery 37: 655-667, 1995.
5. Robertson PL, Zeltzer PM, Boyett JM, Rorke LB, Allen JC, Geyer JR, Stanley P, Li H, Albright AL, McGuire-Cullen P, Finlay JL, Stevens KR Jr, Milstein JM, Packer RJ and Wisoff J: Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg 88: 695-703, 1998. (Pubitemid 28145213)
6. Bouffet E, Perilongo G, Canete A and Massimino M: Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol 30: 319-331, 1998. (Pubitemid 28198926)
7. Castelli MG, Chiabrando C, Fanelli R, Martelli L, Butti G, Gaetani P and Paoletti P: Prostaglandin and thromboxane synthesis by human intracranial tumors. Cancer Res 49: 1505-1508, 1989. (Pubitemid 19088690)
8. Kokoglu E, Tuter Y, Sandikci KS, Yazici Z, Ulakoglu EZ, Sonmez H and Ozyurt E: Prostaglandin E2 levels in human brain tumor tissues and arachidonic acid levels in the plasma membrane of human brain tumors. Cancer Lett 132: 17-21, 1998. (Pubitemid 28535179)
9. Paoletti P, Chiabrando C, Gaetani P, Castelli MG, Butti G, Martelli L and Rolli M: Prostaglandins in human brain tumors. J Neurosurg Sci 33: 65-69, 1989. (Pubitemid 19153231)
10. Pairet M and Engelhardt G: Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Fundam Clin Pharmacol 10: 1-17, 1996.
11. Vane JR, Bakhle YS and Botting RM: Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38: 97-120, 1998. (Pubitemid 28231490)
12. Joki T, Heese O, Nikas DC, Bello L, Zhang J, Kraeft SK, Seyfried NT, Abe T, Chen LB, Carroll RS and Black PM: Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 60: 4926-4931, 2000.
13. Matsuo M, Yonemitsu N, Zaitsu M, Ishii K, Hamasaki Y, Fukuyama K, Tabuchi K and Miyazaki S: Expression of prostaglandin H synthase-2 in human brain tumors. Acta Neuropathol (Bed) 102: 181-187, 2001. (Pubitemid 32771667)
14. Patti R, Gumired K, Reddanna P, Sutton LN, Phillips PC and Reddy CD: Overexpression of cyclooxygenase-2 (COX-2) in human primitive neuroectodermal tumors: effect of celecoxib and rofecoxib. Cancer Lett 180: 13-21, 2002. (Pubitemid 34245438)
15. Shono T, Tofilon PJ, Bruner JM, Owolabi O and Lang FF: Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res 61: 4375-4381, 2001. (Pubitemid 32685762)
16. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M and DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705-716, 1998. (Pubitemid 28257578)
17. Tsujii M and DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493-501, 1995.
18. Liu XH, Yao S, Kirschenbaum A and Levine AC: NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res 58: 4245-4249, 1998. (Pubitemid 28450018)
19. Yao R, Rioux N, Castonguay A and You M: Inhibition of COX-2 and induction of apoptosis: two determinants of non-steroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis. Exp Lung Res 26:731-742, 2000. (Pubitemid 32044588)
20. Li M, Wu X and Xu XC: Induction of apoptosis by cyclooxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells. Int J Cancer 93: 218-223, 2001. (Pubitemid 32574278)
21. Endicott JA and Ling V: The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58: 137-171, 1989. (Pubitemid 19172967)
22. Gottesman MM, Pastan I and Ambudkar SV: P-glycoprotein and multidrug resistance. Curr Opin Genet Dev 6: 610-617, 1996. (Pubitemid 26372158)
23. Ueda K, Cornwell MM, Gottesman MM, Pastan I, Roninson IB, Ling V and Riordan JR: The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun 141: 956-962, 1986. (Pubitemid 17006141)
24. Henson JW, Cordon-Cardo C and Posner JB: P-glycoprotein expression in brain tumors. J Neurooncol 14: 37-43, 1992.
25. Chou PM, Barquin N, Gonzalez-Crussi F, Ridaura Sanz C, Tomita T and Reyes-Mugica M: Ependymomas in children express the multidrug resistance gene: immunohistochemical and molecular biologic study. Pediatr Pathol Lab Med 16: 551-561, 1996. (Pubitemid 26268687)
26. Geddes JF, Vowles GH, Ashmore SM, Cockburn HA and Darling JL: Detection of multidrug resistance gene product (P-glycoprotein) expression in ependymomas. Neuropathol Appl Neurobiol 20: 118-121, 1994. (Pubitemid 24123542)
27. Fantappie O, Masini E, Sardi I, Raimondi L, Bani D, Solazzo M, Vannacci A and Mazzanti R: The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line. Hepatology 35: 843-852, 2002. (Pubitemid 34258378)
28. Patel VA, Dunn MJ and Sorokin A: Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2. J Biol Chem 277: 38915-38920, 2002. (Pubitemid 35154756)
29. Ratnasinghe D, Daschner PJ, Anver MR, Kasprzak BH, Taylor PR, Yeh GC and Tangrea JA: Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible? Anticancer Res 21: 2141-2147 2001. (Pubitemid 32728881)
30. Ziemann C, Schäfer D, Rudell G, Kahl GF and Hirsch-Ernst KI: The cyclooxygenase system participates in functional mdrlb overexpression in primary rat hepatocyte cultures. Hepatology 35: 579-588, 2002. (Pubitemid 34183961)